In 2021, the FDA approved Novo Nordisk's Wegovy, a slight reformulation of Ozempic designed specifically for weight loss, which drove a huge spike in public awareness of GLP-1 agonists
"Folate and cobalamin in psychiatric illness"
A large BMJ study found the overall risk is small but higher than with some other diabetes medicines
The latest findings further revealed that the HECT domain-containing ubiquitin E3 ligase HUWE1 was also an underlying protective modulator that could combat ferroptosis and abnormal iron accumulation by diminishing the amassing of TfR1, reducing the risk of ALF (Wu et al., 2022)
Sung W-W, Wang Y-C, Lin P-L, Cheng Y-W, Chen C-Y, Wu T-C, et al